The Mood and Anxiety Disorders Program (MAP) is the largest and longest running clinical research program in Emory’s Department of Psychiatry and Behavioral Sciences. MAP has been conducting NIH- and industry-funded clinical trials of major depression, PTSD, social phobia, generalized anxiety disorder, obsessive-compulsive disorder and panic disorder for over 30 years. MAP is located on the third floor of the Executive Park 12 (EP12) building. MAP operates in a suite of 8 offices, plus additional rooms for physical exams, phlebotomy, electrocardiograms, laboratory with refrigerated centrifuges, storage (including dry- ice storage equipment, and -20ºC and -80ºC freezers), psychedelic and MDMA dosing rooms, and a conference room. Psychedelic and MDMA dosing rooms are equipped with capacity for continuous audiovisual recording, with furnishings appropriate for the safe setting for conducting sessions. The program is fully equipped with desktop computers, printers, fax machines, photocopier, supplies, and video-taping equipment. MAP personnel have extensive clinical experience through conduct of both NIH-funded and industry-funded trials. A wide range of clinical programs and centers support MAP clinical trials. Connected to Emory’s Department of Psychiatry and Behavioral Sciences, these programs and centers include Emory Healthcare’s Adult Psychiatry and Behavioral Sciences Program, the Fuqua Center for Late-Life Depression, the Emory Child and Adolescent Mood Program, and the Emory Center for Psychedelics and Spirituality.